Two new kaurane-type diterpenoids from Wedelia chinensis (Osbeck.) Merr
Cai, Cancan1,2; Zhang, Yu1; Yang, Dongqiong1,2; Hao, Xiaojiang1; Li, Shunlin1
2017
发表期刊NATURAL PRODUCT RESEARCH
ISSN1478-6419
卷号31期号:21页码:2531-2536
摘要Two new kaurane-type diterpenoids, 3 alpha-(angeloyloxy)-17-hydroxyent-kaur-15-en-19-oic acid (1) and 3 alpha-(tigloyloxy)-17-hydroxy-entkaur- 15-en-19-oic acid (2), along with 10 known compounds (3-12) were isolated from the whole plant of Wedelia chinensis (Osbeck.) Merr. Their structures were elucidated on the basis of extensive spectroscopic analyses (UV, IR, MS and NMR) and comparison with literature data. Compounds 3 and 4 showed moderate inhibitory activity against the Staphylococcus aureus subsp. aureus ATCC29213 with MIC50 19.35 and 18.31 mu g/mL, respectively.
关键词Wedelia Chinensis Kauranetype Diterpenoids Antibacterial Activity
收录类别SCI
语种英语
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/54971
专题植物化学与西部植物资源持续利用国家重点实验室
作者单位1.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ci, Kunming, Yunnan, Peoples R China
2.Univ Chinese Acad Sci, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Cai, Cancan,Zhang, Yu,Yang, Dongqiong,et al. Two new kaurane-type diterpenoids from Wedelia chinensis (Osbeck.) Merr[J]. NATURAL PRODUCT RESEARCH,2017,31(21):2531-2536.
APA Cai, Cancan,Zhang, Yu,Yang, Dongqiong,Hao, Xiaojiang,&Li, Shunlin.(2017).Two new kaurane-type diterpenoids from Wedelia chinensis (Osbeck.) Merr.NATURAL PRODUCT RESEARCH,31(21),2531-2536.
MLA Cai, Cancan,et al."Two new kaurane-type diterpenoids from Wedelia chinensis (Osbeck.) Merr".NATURAL PRODUCT RESEARCH 31.21(2017):2531-2536.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
82.pdf(982KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Cai, Cancan]的文章
[Zhang, Yu]的文章
[Yang, Dongqiong]的文章
百度学术
百度学术中相似的文章
[Cai, Cancan]的文章
[Zhang, Yu]的文章
[Yang, Dongqiong]的文章
必应学术
必应学术中相似的文章
[Cai, Cancan]的文章
[Zhang, Yu]的文章
[Yang, Dongqiong]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 82.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。